+1,314.6%
HWM vs MRNA
+840.0%
+474.6%
-64.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.2% | -3.9% | +5.1% | +1.2% |
| 7D | -1.7% | -17.6% | +15.8% | -1.4% |
| 30D | -2.5% | -5.1% | +2.6% | -2.4% |
| 3M | -25.5% | +220.8% | -246.3% | -27.2% |
| 6M | -17.2% | +321.7% | -338.9% | -20.0% |
| YTD | +5.2% | +601.3% | -596.0% | -0.1% |
| 1Y | +7.7% | +735.2% | -727.5% | +1.7% |
| 3Y | +321.6% | +170.5% | +151.1% | +306.7% |
| 5Y | +593.9% | -14.6% | +608.5% | +570.5% |
| All | +1,314.6% | +840.0% | +474.6% | +1,197.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling